Plasma turnover of HDL apoC-I, apoC-III, and apoE in humans: in vivo evidence for a link between HDL apoC-III and apoA-I metabolism (Q44516309)

3 December 2017

Plasma turnover of HDL apoC-I, apoC-III, and apoE in humans: in vivo evidence for a link between HDL apoC-III and apoA-I metabolism (English)

1 reference

3 December 2017

4

Helene Jacques

1 reference

3 December 2017

8

Jean Davignon

1 reference

3 December 2017

Jeffrey S Cohn

1

1 reference

3 December 2017

Rami Batal

2

1 reference

3 December 2017

Michel Tremblay

3

1 reference

3 December 2017

Lyne Veilleux

5

1 reference

3 December 2017

Claudia Rodriguez

6

1 reference

3 December 2017

Orval Mamer

7

1 reference

3 December 2017

16 July 2003

1 reference

Journal of Lipid Research

3 December 2017

1 reference

3 December 2017

44

1 reference

3 December 2017

10

1 reference

3 December 2017

1976-1983

1 reference

Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study.

3 December 2017

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300209-JLR200

High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300209-JLR200

ATP-binding cassette transporter A1 and cholesterol trafficking

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300209-JLR200

1999 George Lyman Duff memorial lecture: lipid transfer proteins, HDL metabolism, and atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300209-JLR200

Lipases and HDL metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300209-JLR200

Apolipoprotein A-II, HDL metabolism and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300209-JLR200

Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300209-JLR200

Apolipoprotein E: far more than a lipid transport protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300209-JLR200

Effect of the human plasma apolipoproteins and phosphatidylcholine acyl donor on the activity of lecithin. Cholesterol acyltransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300209-JLR200

Effect of serum and C-apoproteins from very low density lipoproteins on human postheparin plasma hepatic lipase

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300209-JLR200

Apolipoprotein C-1 inhibits the hydrolysis by phospholipase A2 of phospholipids in liposomes and cell membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300209-JLR200

Human apolipoprotein C-I accounts for the ability of plasma high density lipoproteins to inhibit the cholesteryl ester transfer protein activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300209-JLR200

Apolipoprotein CI deficiency markedly augments plasma lipoprotein changes mediated by human cholesteryl ester transfer protein (CETP) in CETP transgenic/ApoCI-knocked out mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300209-JLR200

Lipid free apolipoprotein E binds to the class B Type I scavenger receptor I (SR-BI) and enhances cholesteryl ester uptake from lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300209-JLR200

Apolipoprotein specificity for lipid efflux by the human ABCAI transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300209-JLR200

Cubilin, the endocytic receptor for intrinsic factor-vitamin B(12) complex, mediates high-density lipoprotein holoparticle endocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300209-JLR200

Effect of atorvastatin on plasma apoE metabolism in patients with combined hyperlipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300209-JLR200

Plasma kinetics of VLDL and HDL apoC-I in normolipidemic and hypertriglyceridemic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300209-JLR200

Measurement of very low density and low density lipoprotein apolipoprotein (Apo) B-100 and high density lipoprotein Apo A-I production in human subjects using deuterated leucine. Effect of fasting and feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300209-JLR200

Stable isotope turnover of apolipoproteins of high-density lipoproteins in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300209-JLR200

Abnormal in vivo metabolism of apolipoprotein E4 in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300209-JLR200

Increased plasma and renal clearance of an exchangeable pool of apolipoprotein A-I in subjects with low levels of high density lipoprotein cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300209-JLR200

Activation of the enzymic activity of hepatic lipase by apolipoprotein A-II. Characterization of a major component of high density lipoprotein as the activating plasma component in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300209-JLR200

A rapid electrophoretic technique for identification of subunit species of apoproteins in serum lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300209-JLR200

Familial HDL deficiency characterized by hypercatabolism of mature apoA-I but not proapoA-I

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300209-JLR200

Plasma concentration of apolipoprotein E in intermediate-sized remnant-like lipoproteins in normolipidemic and hyperlipidemic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300209-JLR200

Metabolism of apolipoprotein C-I in normolipoproteinemic human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300209-JLR200

In vivo metabolism of apolipoprotein E within the HDL subpopulations LpE, LpE:A-I, LpE:A-II and LpE:A-I:A-II

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300209-JLR200

Human HDL cholesterol levels are determined by apoA-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Effects of gender, hepatic and lipoprotein lipases, triglyceride and insulin levels, and body fat distri

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300209-JLR200

VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300209-JLR200

The apo E/apo CIII molar ratio affects removal of cholesterol ester from modified human lipoproteins injected into cebus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300209-JLR200

10.1194/JLR.M300209-JLR200

21 January 2018

Identifiers

DOI

1 reference

3 December 2017

1 reference